The Dermatology Digest

NOVEMBER 20, 2024

The approval of bimekizumab-bkzx blocker is supported by data from two Phase 3 studies, BE HEARD I and BE HEARD II, which evaluated the efficacy and safety of bimekizumab in the treatment of adults with moderate-to-severe HS. living with moderate-to-severe disease,” says Brindley Brooks, Founder and Executive Director of HS Connect.

Safety 78

Safety Sustainability Clinic Medical 78

The Dermatology Digest

JULY 14, 2024

Following the announced positive primary endpoint in Q1 2023, the one-year readout evaluated long term safety and scar quality. In early 2024, CUTISS AG announced positive one-year follow-up data from its Phase 2 clinical trial of denovoSkin in adult and adolescent severe burn patients.

Surgery 73

Surgery Scarring Safety Clinic 73

Les Nouvelles Esthetics & Spa

JANUARY 31, 2024

We invest heavily in their training, focusing on the intricacies of our products and safety protocols. Without the burden of licensing requirements, we’ve fostered a diverse group of talented individuals. For many, Pure Glow has been a stepping stone to greater achievements in the beauty industry. What is your plan for company growth?

Branding 78

Branding Sales Office Safety 78

New Age Spa Institute

JULY 6, 2023

Las Vegas, known as the entertainment capital of the world, welcomed beauty professionals and skin care enthusiasts from across the globe for the highly anticipated International Esthetics Cosmetics Skincare Conference (IECSC) 2023. Let’s dive into the captivating highlights of this exceptional conference. License renewal.

Esthetics 52

Esthetics Skincare Esthetician Medical Esthetics 52

Aesthetics Advisor

OCTOBER 12, 2023

between 2023 and 2028. Related: Nutritional Synergies of Vitamin D, K2 and Magnesium Best Vitamin D3 and K2 Supplement Brands in 2023 We have done our research and shortlisted the best for you. No GMOs, No Preservatives, No Artificial Colors, No Flavors, No Soy and No Gluten 3rd Party Lab Tested for Purity and Safety.

Ingredients 69

Ingredients Vitamin C Branding Marketing 69

The Dermatology Digest

JANUARY 29, 2024

Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. Zoryve foam was well-tolerated with a favorable safety and tolerability profile. It is the first drug approved for seborrheic dermatitis with a new mechanism of action in over two decades.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

APRIL 4, 2024

The safety profile of Bimzelx was consistent with previous studies with no new safety signals observed. in October 2023 for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. In addition, improvements increased for patients in these studies over 48 weeks.

Safety 57

Safety Injections Clinic Therapy 57

The Dermatology Digest

OCTOBER 30, 2024

Meet La Roche-Posay’s 2023 Young Investigator Grant Winners… Drs. Ultimately, our aim is to improve public health outcomes and raise awareness about the critical importance of sun safety in our communities,” say Drs. Nahar and Huynh in a news release.

Sun Protection 36

Sun Protection Dermatology Safety Innovations 36

The Dermatology Digest

FEBRUARY 8, 2024

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. The BIG story is Janus kinase ( JAK ) inhibitors,” Dr. Martin says.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

FEBRUARY 14, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. Nemolizumab was generally well tolerated and its safety profile was similar to placebo across the OLYMPIA and ARCADIA clinical trial programs.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

DECEMBER 27, 2023

The Skin of Color Society (SOCS) reports that 2023 was a year of exceptional progress for its mission to change the landscape for people with darker skin tones through research, education, mentorship, and advocacy. 2023 Highlights December 2023: The SOCS Meeting the Challenge Summit: Population Descriptors in Dermatology Research Studies.

Education 36

Education Innovations Dermatology Clinic 36

The Dermatology Digest

MAY 16, 2024

Sonelokimab in PsA For PsA, Phase 3 initiation is anticipated in Q4 2024 following the announcement in March 2024 of the full dataset from the global Phase 2 ARGO trial (M1095-PSA-201) evaluating the efficacy and safety of the Nanobody sonelokimab over 24 weeks in patients with active PsA.

Safety 68

Safety Clinic Dermatology Office 68

Alison Bladh

JANUARY 16, 2025

Safety and Precautions While saw palmetto is generally safe, there are a few important considerations to keep in mind: Potential Side Effects Mild digestive issues such as nausea, diarrhoea, or constipation may occur. 2023 Nov 11;16:3251-3266. Its essential to use a reputable brand to ensure quality and effectiveness.

Extractions 98

Extractions Management Consultation Consultations 98

The Dermatology Digest

MARCH 22, 2024

1,2 Benzene has become a more recent focus of attention related to safety concerns, with an increase in independent product testing and also updated regulations by the Food and Drug Administration related to benzene. Public safety is the first priority of the AARS. Right now, there are many questions about this issue. pp 9767-9777.

Rosacea 64

Rosacea Document Safety Ingredients 64

The Dermatology Digest

JULY 26, 2024

The resubmission has been accepted as a complete response to the FDA’s December 2023 complete response letter (CRL) and the FDA has set a Prescription Drug User Fee Act (PDUFA) goal date of December 28, 2024. The CRL did not state any concerns about the clinical data package, safety, or labeling for the approvability of cosibelimab.

Treatments 36

Treatments Surgery Safety Clinic 36

West Lake Dermatology

JANUARY 10, 2025

million cosmetic procedures performed in 2023 in the United States, with injectables like Botox and dermal fillers topping the charts. This comprehensive guide will help you recognize red flags, ask the right questions, and prioritize your safety. The global demand for cosmetic procedures has surged in recent years.

Legal 36

Legal Safety Injections Ethics 36

The Dermatology Digest

APRIL 30, 2024

Lebrikizumab Timeline October 2023 The U.S. There were no concerns with lebrikizumab’s clinical data package, safety, or label.

Dermatitis 36

Dermatitis Safety Clinic Dermatology 36

Aesthetics Advisor

FEBRUARY 1, 2024

But about 11% of the time, 4 medical conditions are misdiagnosed, according to research published in BMJ Quality & Safety. In 2016, Johns Hopkins patient safety experts, led by Dr. Martin Makary, calculated that more than 250,000 patients died each year from medical errors, making it the third leading cause of death.

Medical 36

Medical Hospital Safety Training 36

Aesthetics Advisor

OCTOBER 7, 2023

For example, in September 2023, it was discovered that counterfeit versions of Pure Encapsulations L-glutamine and NatureMD’s GutConnect 365 were sold Amazon. In August 2023, it was revealed that a counterfeit version of Bausch + Lomb’s PreserVision AREDS 2 Eye Vitamin & Mineral supplement had been sold on Amazon.

Branding 69

Branding Document Product Review Safety 69

Aesthetics Advisor

AUGUST 7, 2023

The 2023 report from the World Obesity Federation estimates that the economic impact of overweight and obesity will surpass $4.3 In April 2023, a spokesperson for Novo Nordisk, maker of semaglutide, said the drugs are now available in pharmacies nationwide. A broad range of drug interventions can help. trillion annually by 2035.

Diet 36

Diet Extractions Medical Sustainability 36

The Eco Well Blog

JUNE 14, 2024

2023), when consumers had the option between “mineral” and “chemical” sunscreens, when blinded, overwhelmingly they preferred the “chemical” sunscreen. So now we’re okay with less safety data over an ingredient that has more safety data? Sunscreen application, safety, and sun protection: the evidence. Colantonio, S.,

Sun Protection 52

Sun Protection Safety Ingredients Marketing 52

The Dermatology Digest

SEPTEMBER 30, 2024

In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. Otulfi demonstrated comparable efficacy, safety, pharmacokinetics and immunogenicity to Stelara in patients with moderate to severe psoriasis vulgaris.

Portfolios 36

Portfolios Partnerships Marketing Safety 36

New Age Spa Institute

JUNE 8, 2023

INGLOT places importance on ingredient safety, ethical practices and sustainability. The next full-time professional makeup certification is from August 21, 2023 to August 31, 2023, Monday through Thursday, 9:00 a.m. They also offer a wide selection of vegan and cruelty-free cosmetic options. to 5:00 p.m. to 5:00 p.m.

Makeup 52

Makeup Training Esthetics Hydration 52

Aesthetics Advisor

SEPTEMBER 27, 2023

And, as mentioned, most Americans get approximately 25% of their total daily calories from seed oils, so we're far over the safety threshold for these fats — at least based on the laboratory work in animals. Lipids 2 Nutrients 2023, 15(14), 3129; doi: 10.3390/nu15143129 3 Open Oregon. Sources and References 1 Britannica.

Diet 36

Diet Ingredients Download Safety 36

The Dermatology Digest

JANUARY 13, 2025

Proof-of-concept efficacy and safety data from a Phase1bstudy of rezpegaldesleukin in atopic dermatitis patients were presented at the 2023 EADV Congress. This trial was initiated inOctober 2023.

Dermatitis 36

Dermatitis Clinic Eczema Therapy 36

The Dermatology Digest

APRIL 23, 2024

The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel. The BLA for pz-cel was accepted for filing and granted priority review designation by the FDA in November 2023.

Marketing 36

Marketing Safety Clinic Sustainability 36

Aesthetics Advisor

APRIL 26, 2024

As this substance infiltrates the American food supply, the potential risks to our health and future generations loom larger, raising urgent questions about the safety of our everyday food choices. In April of 2023, the EPA proposed allowing the first-ever use of chlormequat on barley, oat, wheat, and triticale grown in the United States.

Document 36

Document Safety Sales Diet 36

Aesthetics Advisor

DECEMBER 3, 2023

The Timing of Your Supplements Matters When and how you take supplements — such as with or without food and in the morning or evening — can make a difference in their safety and effectiveness. 2023 Jan; 16(1): 130., CDC, NCHS Data Brief No. Abstract 7 International Journal of Nanomedicine January 19.

Vitamin C 36

Vitamin C Retinol Collagen Diet 36

The Dermatology Digest

JULY 10, 2024

The treatment was approved by the European Commission and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in December 2023. The letter stated no concerns about the clinical data package, safety, or label for lebrikizumab.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

Aesthetics Advisor

AUGUST 6, 2023

More research is being done to determine the safety of the keto diet in the long term. Anyone taking this medication should avoid the keto diet ( 40 Trusted Source , 41 Trusted Source ). Keep your doctor informed of your eating plan to guide your choices.

Diet 36

Diet Medical Management Sustainability 36

The Dermatology Digest

MARCH 11, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. No new safety signals were observed in this trial.

Dermatitis 36

Dermatitis Safety Eczema Dermatology 36

The Dermatology Digest

MAY 1, 2024

The low-concentration (50 mg/mL), citrate-free formulation of Cyltezo has been commercially available since July 2023. “Biologics and biosimilars are a crucial treatment option for many living with psoriatic arthritis or psoriasis,” says Leah M.

Clinic 36

Clinic Injections Safety Branding 36

West Lake Dermatology

NOVEMBER 1, 2023

Updated on November 2, 2023 Undesirable arm contour can be a source of self-doubt, to the point where it affects our quality of life. Originally published on July 5, 2017. Loose upper arm skin is most often associated with some amount of weight loss.

Surgery 69

Surgery Scarring Consultation Consultations 69

Aesthetics Advisor

APRIL 9, 2024

from 2023 to 2033. The market stands at a valuation of US 12 billion in 2023 and is expected to reach US 20 billion by 2033-end. Safety and side effects of olive oil Olive oil is generally safe and well-tolerated, but it may interact with certain medications (see Concerns and Cautions ). Let's dive in. What is avocado oil?

Marketing 36

Marketing Safety Extractions Medical 36

Associated Skin Care Professionals

AUGUST 16, 2023

In addition to its goal of eliminating toxic beauty standards and empowering youth, the Dove Self Esteem Project also announced its plans to address the rise in youth mental health issues linked to social media with the Campaign for Kids Online Safety. 80% of young people believe people their age are addicted to social media. 

Social Media 40

Social Media Partnerships Branding Education 40

The Dermatology Digest

JANUARY 4, 2024

The clinical results demonstrated that DMB-3115 and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of quality, safety and efficacy. In October of 2023, Accord BioPharma reached a settlement with Janssen Biotech Inc., commercialization.

Pharmaceutical 36

Pharmaceutical Partnerships Clinic Safety 36

First Derm

DECEMBER 26, 2023

Accessed December 26, 2023. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff–a postmarketing study. Accessed December 26, 2023. Published September 4, 2023. Accessed December 26, 2023. Accessed December 26, 2023.

Management 49

Management Dermatitis Eczema Consultations 49